Samir Kumar Patra

Prof. Samir Kumar Patra

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Verified
Journal Article
Closed access
SPSamir Kumar Patra
Samir Kumar Patra

1 December 2019 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
AMAbtar Mishra
Abtar Mishra
ABAssirbad Behura
Assirbad Behura
SMShradha Mawatwal
Shradha Mawatwal
AKAshish Kumar
Ashish Kumar
LNLincoln Naik
Lincoln Naik
RDRohan Dhiman
Rohan Dhiman

1 January 2013
Verified
Book Chapter
Closed access
SBSujit K Bhutia
Sujit K Bhutia
SMSubhadip Mukhopadhyay
Subhadip Mukhopadhyay
NSNiharika Sinha
Niharika Sinha
DDDurgesh Nandini Das
Durgesh Nandini Das
PPPrashanta Kumar Panda
Prashanta Kumar Panda
PFPaul B Fisher
Paul B Fisher

20 February 2002 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
PDF file
SPSamir Kumar Patra
Samir Kumar Patra
APAditi Patra
Aditi Patra
HZHong Zhao
Hong Zhao
RDRajvir Dahiya
Rajvir Dahiya

18 September 2013 in Journal of Histochemistry & Cytochemistry
Verified
Journal Article
Open access
SPSabnam Parbin
Sabnam Parbin
SKSwayamsiddha Kar
Swayamsiddha Kar
ASArunima Shilpi
Arunima Shilpi
DSDipta Sengupta
Dipta Sengupta
MDMoonmoon Deb
Moonmoon Deb
SPSamir Kumar Patra
Samir Kumar Patra
In the current era of genomic medicine, diseases are identified as manifestations of anomalous patterns of gene expression. Cancer is the principal example among such maladies. Although remarkable progress has been achieved in the understanding of the molecular mechanisms involved in the genesis and progression of cancer, its epigenetic regulation, particularly histone deacetylation, demands further studies. Histone deacetylases (HDACs) are one of the key players in the gene expression regulation network in cancer because of their repressive role on tumor suppressor genes. Higher expression and function of deacetylases disrupt the finely tuned acetylation homeostasis in both histone and non-histone target proteins. This brings about alterations in the genes implicated in the regulation of cell proliferation, differentiation, apoptosis and other cellular processes. Moreover, the reversible nature of epigenetic modulation by HDACs makes them attractive targets for cancer remedy. This review summarizes the current knowledge of HDACs in tumorigenesis and tumor progression as well as their contribution to the hallmarks of cancer. The present report also describes briefly various assays to detect histone deacetylase activity and discusses the potential role of histone deacetylase inhibitors as emerging epigenetic drugs to cure cancer.

1 September 2001 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
SPSamir Kumar Patra
Samir Kumar Patra
APAditi Patra
Aditi Patra
RDRajvir Dahiya
Rajvir Dahiya